المؤلفون: Giri, Smith Grimshaw, Alyssa Bal, Susan Godby, KN Kharel, Prakash Djulbegovic, Benjamin Dimopoulos, Meletios A Facon, Thierry Usmani, Saad Z Mateos, Mara-Victoria others

مصطلحات موضوعية: Health Sciences, Επιστήμες Υγείας

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::524f2a2e9c0817dc83fb7d6f322f3c74
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2952970

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Arnold KD; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ong KL; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ravi G; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Cutshall H; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Purnell K; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Wessel MC; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Godby KN; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Bal S; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Giri S; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Rogers LQ; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Demark-Wahnefried W; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Davies FE; Perlmutter Comprehensive Cancer Center, Langone Medical Center, New York University, New York, NY, 10021, USA., Costa LJ; Division of Hematology and Medical Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Morgan GJ; Perlmutter Comprehensive Cancer Center, Langone Medical Center, New York University, New York, NY, 10021, USA., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA., Brown EE; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. elizabethbrown@uabmc.edu.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. elizabethbrown@uabmc.edu.

المصدر: British journal of cancer [Br J Cancer] 2024 Jun 07. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

المؤلفون: Callander NS; University of Wisconsin Carbone Cancer Center, Madison, WI, USA. nsc@medicine.wisc.edu., Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Godby KN; University of Alabama at Birmingham Hospital, Birmingham, AL, USA., Laubach J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Schmidt TM; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Sborov DW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Medvedova E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Reeves B; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Dhakal B; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Rodriguez C; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chhabra S; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bal S; University of Alabama at Birmingham Hospital, Birmingham, AL, USA., Anderson LD Jr; Myeloma, Waldenstrӧm's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Dholaria BR; Vanderbilt University Medical Center, Nashville, TN, USA., Nathwani N; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Hari P; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Holstein SA; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Costello C; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA., Wildes TM; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Cowan AJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Giri S; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Costa LJ; University of Alabama at Birmingham Hospital, Birmingham, AL, USA., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA. usmanis@mskcc.org., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, NC, USA. Peter.Voorhees@atriumhealth.org.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Apr 22; Vol. 14 (1), pp. 69. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/genetics , Multiple Myeloma*/therapy , Multiple Myeloma*/mortality , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Chromosome Aberrations ; Adult ; Lenalidomide/therapeutic use ; Lenalidomide/administration & dosage ; Lenalidomide/adverse effects ; Dexamethasone/administration & dosage ; Dexamethasone/therapeutic use

المؤلفون: Ravi G; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Joiner L; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, Alabama, USA., Giri S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Sentell M; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hill T; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA., Godby KN; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Costa LJ; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1300-1306. Date of Electronic Publication: 2024 Jan 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy , Hematopoietic Stem Cell Transplantation*, Humans ; Bortezomib/therapeutic use ; Transplantation, Autologous ; Disease Progression ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone/therapeutic use

المؤلفون: Joiner L; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, Alabama, USA., Bal S; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Godby KN; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Nov; Vol. 98 (11), pp. E322-E324. Date of Electronic Publication: 2023 Aug 23.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

المؤلفون: Costa LJ; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ljcosta@uabmc.edu., Chhabra S; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Medvedova E; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR, USA., Dholaria BR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Schmidt TM; Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisc onsin, Madison, WI, USA., Godby KN; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Silbermann R; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR, USA., Dhakal B; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Giri S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., D'Souza A; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Hall AC; Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisc onsin, Madison, WI, USA., Hardwick P; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Omel J; Academic Consortium to Overcome Multiple Myeloma through Innovative Trials (COMMIT), Omaha, NE, USA., Cornell RF; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Hari P; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Callander NS; Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisc onsin, Madison, WI, USA.

المصدر: The Lancet. Haematology [Lancet Haematol] 2023 Nov; Vol. 10 (11), pp. e890-e901. Date of Electronic Publication: 2023 Sep 27.

نوع المنشور: Clinical Trial, Phase II; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy, Male ; Humans ; Female ; Middle Aged ; Aged ; Lenalidomide/therapeutic use ; Neoplasm, Residual ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone/adverse effects

المؤلفون: Wellman TJ; Invicro, a Konica Minolta Company, 119 4th Ave, Needham Heights, MA 02494, USA., Mudd SR; AbbVie, Inc., 1 North Waukegan Rd, North Chicago, IL 60064, USA., Godby KN; The University of Alabama at Birmingham School of Medicine, 1670 University Blvd, Birmingham, AL 35233, USA., Wooten DW; AbbVie, Inc., 1 North Waukegan Rd, North Chicago, IL 60064, USA., Ross JA; AbbVie, Inc., 1 North Waukegan Rd, North Chicago, IL 60064, USA., Bueno OF; AbbVie, Inc., 1 North Waukegan Rd, North Chicago, IL 60064, USA., Wanik D; Invicro, a Konica Minolta Company, 119 4th Ave, Needham Heights, MA 02494, USA., Divgi CR; Invicro, a Konica Minolta Company, 119 4th Ave, Needham Heights, MA 02494, USA., Comley RA; AbbVie, Inc., 1 North Waukegan Rd, North Chicago, IL 60064, USA., Costa LJ; The University of Alabama at Birmingham School of Medicine, 1670 University Blvd, Birmingham, AL 35233, USA., Hesterman JY; Invicro, a Konica Minolta Company, 119 4th Ave, Needham Heights, MA 02494, USA. Electronic address: jhesterman@ratiotx.com.

المصدر: Translational oncology [Transl Oncol] 2023 Nov; Vol. 37, pp. 101767. Date of Electronic Publication: 2023 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE

المؤلفون: Jamy O; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. omerjamy@uabmc.edu., Diebold K; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Davis K; School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Bachiashvili K; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Rangaraju S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Vachhani P; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Godby KN; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Salzman D; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia R; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2023 Jul; Vol. 58 (7), pp. 823-825. Date of Electronic Publication: 2023 Apr 03.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy, Humans ; Mutation ; Karyotype ; Tumor Suppressor Protein p53/genetics ; Prognosis

المؤلفون: Silbermann RW; Knight Cancer Institute Oregon Health and Science University Portland Oregon USA., Schmidt TM; Carbone Cancer Center University of Wisconsin Madison Wisconsin USA., Bal S; University of Alabama at Birmingham Birmingham AL UK., Dhakal B; Division of Hematology/Oncology, Department of Medicine Medical College of Wisconsin Milwaukee Wisconsin USA., Dholaria B; Vanderbilt University Medical Center Nashville TN USA., Biltibo E; Vanderbilt University Medical Center Nashville TN USA., Chhabra S; Division of Hematology/Oncology, Department of Medicine Medical College of Wisconsin Milwaukee Wisconsin USA., Giri S; Institute for Cancer Outcomes and Survivorship University of Alabama at Birmingham Birmingham AL UK., Godby KN; University of Alabama at Birmingham Birmingham AL UK., Gowda S; Department of Internal Medicine Oregon Health and Science University Portland Oregon USA., Medvedova E; Knight Cancer Institute Oregon Health and Science University Portland Oregon USA., Cornell RF; Vanderbilt University Medical Center Nashville TN USA., Callander NS; Carbone Cancer Center University of Wisconsin Madison Wisconsin USA., Costa LJ; University of Alabama at Birmingham Birmingham AL UK.

المصدر: EJHaem [EJHaem] 2023 Jun 22; Vol. 4 (3), pp. 775-778. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE